NCT06816719 - To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

November 2, 2024

Study Completion Date

November 12, 2024

Conditions

Healthy

Interventions

DRUG

Treatment A: JW0106 1 tablet + C2101 1 tablet

"* Co-administration of 1 tablet of JW0106 and 1 tablet of C2101~* Administration orally with 150 mL of water under fasting conditions"

DRUG

Treatment B: JW0107 1 tablet

"* Administration alone of 1 tablet of JW0107~* Administration orally with 150 mL of water under fasting conditions"

Trial Locations (1)

Clinical Trial Center, Jeonbuk National University Hospital, Jeonju